List of clinical studies of hormonal birth control (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "List of clinical studies of hormonal birth control" in English language version.

refsWebsite

Global rank English rank

14nih.gov

4^th place

11doi.org

2^nd place

4semanticscholar.org

11^th place

8^th place

1books.google.com

3^rd place

1worldcat.org

5^th place

1kup.at

low place

1harvard.edu

18^th place

17^th place

books.google.com

Savitri Ramcharan, ed. (1974). Walnut Creek Contraceptive Drug Study: A Prospective Study of the Side Effects of Oral Contraceptives, Volume 3. National Institute of Child Health and Human Development, Center for Population Research. OCLC 1279046.

doi.org

Grant EC, Robinson J (May 1981). "The R.C.G.P. oral contraception study". Lancet. 1 (8231): 1206–7. doi:10.1016/s0140-6736(81)92366-7. PMID 6112543. S2CID 20271773.
Vessey MP, Lawless M (December 1984). "The Oxford-Family Planning Association contraceptive study". Clinics in Obstetrics and Gynaecology. 11 (3): 743–57. doi:10.1016/S0306-3356(21)00625-7. PMID 6509857.
Toppozada MK (April 1994). "Existing once-a-month combined injectable contraceptives". Contraception. 49 (4): 293–301. doi:10.1016/0010-7824(94)90029-9. PMID 8013216.
Koetsawang S (1991). "The injectable contraceptive: present and future trends". Ann. N. Y. Acad. Sci. 626 (1): 30–42. Bibcode:1991NYASA.626...30K. doi:10.1111/j.1749-6632.1991.tb37897.x. PMID 1829341. S2CID 27008012.
Oral Contraceptive Hemostasis Study Group (March 2003). "The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study". Contraception. 67 (3): 173–85. doi:10.1016/s0010-7824(02)00476-6. PMID 12618251.
"An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group". Contraception. 59 (6): 345–55. June 1999. doi:10.1016/s0010-7824(99)00044-x. PMID 10518228.
Hugon-Rodin J, Gompel A, Plu-Bureau G (December 2014). "Epidemiology of hormonal contraceptives-related venous thromboembolism". Eur J Endocrinol. 171 (6): R221–30. doi:10.1530/EJE-14-0527. PMID 25012200.
Dinger J, Do Minh T, Heinemann K (October 2016). "Impact of estrogen type on cardiovascular safety of combined oral contraceptives". Contraception. 94 (4): 328–39. doi:10.1016/j.contraception.2016.06.010. PMID 27343748.
Morimont L, Haguet H, Dogné JM, Gaspard U, Douxfils J (2021). "Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk". Front Endocrinol (Lausanne). 12: 769187. doi:10.3389/fendo.2021.769187. PMC 8697849. PMID 34956081.
Grandi G, Facchinetti F, Bitzer J (February 2022). "Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism". Eur J Contracept Reprod Health Care. 27 (2): 83–84. doi:10.1080/13625187.2022.2029397. PMID 35133236. S2CID 246651102.
Reed S, Koro C, DiBello J, Becker K, Bauerfeind A, Franke C, Heinemann K (December 2021). "Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism". Eur J Contracept Reprod Health Care. 26 (6): 439–446. doi:10.1080/13625187.2021.1987410. PMID 34644228. S2CID 238858357.

harvard.edu

ui.adsabs.harvard.edu

Koetsawang S (1991). "The injectable contraceptive: present and future trends". Ann. N. Y. Acad. Sci. 626 (1): 30–42. Bibcode:1991NYASA.626...30K. doi:10.1111/j.1749-6632.1991.tb37897.x. PMID 1829341. S2CID 27008012.

kup.at

Benagiano, G., & Merialdi, M. (2011). Carl Djerassi and the World Health Organisation special programme of research in human reproduction. Journal für Reproduktionsmedizin und Endokrinologie-Journal of Reproductive Medicine and Endocrinology, 8(1), 10-13. http://www.kup.at/kup/pdf/10163.pdf

nih.gov

pubmed.ncbi.nlm.nih.gov

Rosenfield A (May 1982). "The pill: an evaluation of recent studies". Johns Hopkins Med J. 150 (5): 177–80. PMID 7043036.
Grant EC, Robinson J (May 1981). "The R.C.G.P. oral contraception study". Lancet. 1 (8231): 1206–7. doi:10.1016/s0140-6736(81)92366-7. PMID 6112543. S2CID 20271773.
Vessey MP, Lawless M (December 1984). "The Oxford-Family Planning Association contraceptive study". Clinics in Obstetrics and Gynaecology. 11 (3): 743–57. doi:10.1016/S0306-3356(21)00625-7. PMID 6509857.
Ramcharan S, Pellegrin FA, Ray RM, Hsu JP (December 1980). "The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III, an interim report: A comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives". J Reprod Med. 25 (6 Suppl): 345–72. PMID 7205804.
Toppozada MK (April 1994). "Existing once-a-month combined injectable contraceptives". Contraception. 49 (4): 293–301. doi:10.1016/0010-7824(94)90029-9. PMID 8013216.
Koetsawang S (1991). "The injectable contraceptive: present and future trends". Ann. N. Y. Acad. Sci. 626 (1): 30–42. Bibcode:1991NYASA.626...30K. doi:10.1111/j.1749-6632.1991.tb37897.x. PMID 1829341. S2CID 27008012.
Oral Contraceptive Hemostasis Study Group (March 2003). "The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study". Contraception. 67 (3): 173–85. doi:10.1016/s0010-7824(02)00476-6. PMID 12618251.
"An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group". Contraception. 59 (6): 345–55. June 1999. doi:10.1016/s0010-7824(99)00044-x. PMID 10518228.
Hugon-Rodin J, Gompel A, Plu-Bureau G (December 2014). "Epidemiology of hormonal contraceptives-related venous thromboembolism". Eur J Endocrinol. 171 (6): R221–30. doi:10.1530/EJE-14-0527. PMID 25012200.
Dinger J, Do Minh T, Heinemann K (October 2016). "Impact of estrogen type on cardiovascular safety of combined oral contraceptives". Contraception. 94 (4): 328–39. doi:10.1016/j.contraception.2016.06.010. PMID 27343748.
Morimont L, Haguet H, Dogné JM, Gaspard U, Douxfils J (2021). "Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk". Front Endocrinol (Lausanne). 12: 769187. doi:10.3389/fendo.2021.769187. PMC 8697849. PMID 34956081.
Grandi G, Facchinetti F, Bitzer J (February 2022). "Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism". Eur J Contracept Reprod Health Care. 27 (2): 83–84. doi:10.1080/13625187.2022.2029397. PMID 35133236. S2CID 246651102.
Reed S, Koro C, DiBello J, Becker K, Bauerfeind A, Franke C, Heinemann K (December 2021). "Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism". Eur J Contracept Reprod Health Care. 26 (6): 439–446. doi:10.1080/13625187.2021.1987410. PMID 34644228. S2CID 238858357.

ncbi.nlm.nih.gov

Morimont L, Haguet H, Dogné JM, Gaspard U, Douxfils J (2021). "Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk". Front Endocrinol (Lausanne). 12: 769187. doi:10.3389/fendo.2021.769187. PMC 8697849. PMID 34956081.

semanticscholar.org

api.semanticscholar.org

Grant EC, Robinson J (May 1981). "The R.C.G.P. oral contraception study". Lancet. 1 (8231): 1206–7. doi:10.1016/s0140-6736(81)92366-7. PMID 6112543. S2CID 20271773.
Koetsawang S (1991). "The injectable contraceptive: present and future trends". Ann. N. Y. Acad. Sci. 626 (1): 30–42. Bibcode:1991NYASA.626...30K. doi:10.1111/j.1749-6632.1991.tb37897.x. PMID 1829341. S2CID 27008012.
Grandi G, Facchinetti F, Bitzer J (February 2022). "Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism". Eur J Contracept Reprod Health Care. 27 (2): 83–84. doi:10.1080/13625187.2022.2029397. PMID 35133236. S2CID 246651102.
Reed S, Koro C, DiBello J, Becker K, Bauerfeind A, Franke C, Heinemann K (December 2021). "Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism". Eur J Contracept Reprod Health Care. 26 (6): 439–446. doi:10.1080/13625187.2021.1987410. PMID 34644228. S2CID 238858357.

worldcat.org

search.worldcat.org

Savitri Ramcharan, ed. (1974). Walnut Creek Contraceptive Drug Study: A Prospective Study of the Side Effects of Oral Contraceptives, Volume 3. National Institute of Child Health and Human Development, Center for Population Research. OCLC 1279046.